Ms Melissa Kerr
Clinical Trial Project Manager
Centre for Youth Mental Health (Orygen)
58 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Effects of 6-months of SSRI use on DNA-methylation and gene expression in blood
DOI: 10.1016/j.bbi.2026.1065202026
Journal article
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for Psychosis
DOI: 10.1111/eip.701832026
Journal article
Feasibility of a Stepped-Care Intervention for Those at Clinical High Risk for Psychosis in the United States
DOI: 10.1111/eip.701202025
Journal article
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk Individuals
DOI: 10.1093/schbul/sbae2042025
Journal article
Therapy process factors in early psychosis: The effect of working alliance on clinical symptoms and cognitive biases in Ultra High Risk young people
DOI: 10.1016/j.schres.2025.07.0312025
Journal article
White Blood Cell Proportions Are Associated With Response to Psychosocial Therapy in Young People at Ultra-High Risk for Psychosis
DOI: 10.1016/j.bpsgos.2025.1005462025
Journal article
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
DOI: 10.1093/schbul/sbae149
RECENT SCHOLARLY WORKS
2025
Journal article
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
DOI: 10.1093/schizbullopen/sgaf0132025
Journal article
Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
DOI: 10.1093/schizbullopen/sgaf0122025
Journal article
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program
DOI: 10.1038/s41537-025-00556-7